Castle Biosciences, Inc.
US ˙ NasdaqGM ˙ US14843C1053

SecurityCSTL / Castle Biosciences, Inc.
InsiderTiffany Olson
This page shows the track record and history of Olson Tiffany insider trades in Castle Biosciences, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Tiffany Olson in CSTL / Castle Biosciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-11-29 1,162 21.5000 1,162 21.5000 24,983 65 28.4900 8,122 32.51
2022-05-12 1,100 18.7600 1,100 18.7600 20,636
2022-05-12 220 18.7700 220 18.7700 4,129

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CSTL / Castle Biosciences, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Tiffany Olson in CSTL / Castle Biosciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CSTL / Castle Biosciences, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-27 2026-05-22 4 Olson Tiffany CSTL Common Stock M - Exercise D 13,667 39,573
2025-05-23 2025-05-21 4 Olson Tiffany CSTL Common Stock M - Exercise D 8,673 25,906
2024-07-03 2024-07-01 4 Olson Tiffany CSTL Common Stock M - Exercise D 830 17,233
2024-05-29 2024-05-25 4 Olson Tiffany CSTL Common Stock M - Exercise D 8,636 16,403
2024-05-14 2024-05-10 4 Olson Tiffany CSTL Common Stock M - Exercise D 487 7,767
2023-06-06 2023-06-02 4 Olson Tiffany CSTL Common Stock M - Exercise D 3,825 7,280
2023-05-12 2023-05-10 4 Olson Tiffany CSTL Common Stock M - Exercise D 487 3,455
2022-12-01 2022-11-29 4 Olson Tiffany CSTL Common Stock P - Purchase D 21.5000 1,162 25 2,968
2022-07-07 2022-05-12 4 Olson Tiffany CSTL Common Stock P - Purchase D 18.7700 220 4 1,806
2022-07-07 2022-05-12 4 Olson Tiffany CSTL Common Stock P - Purchase D 18.7600 1,100 21 1,586
2022-05-12 2022-05-10 4 Olson Tiffany CSTL Restricted Stock Units M - Exercise D -486 974
2022-05-12 2022-05-10 4 Olson Tiffany CSTL Common Stock M - Exercise D 486 486
2021-05-12 2021-05-10 4 Olson Tiffany CSTL Restricted Stock Units A - Award D 1,460 1,460
2021-05-12 2021-05-10 4 Olson Tiffany CSTL Stock option (right to buy) A - Award D 54.78 5,936 5,936
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)